Quanterix Competitors and Similar CompaniesClear all
Quanterix's competitors and similar companies include Olink, SomaLogic, Otsuka Novel Products and IMIDomics.
 Quanterix Quanterix is a platform for single molecule analysis that supports clinical diagnostics, drug development, and life science researches. |  Olink Olink Proteomics is a company providing products and services for human protein biomarker discovery. |  SomaLogic SomaLogic's breakthrough SOMAscan(tm) technology unlocks protein biomarkers for life sciences research, drug discovery and development, and new diagnostics. |  Otsuka Novel Products Otsuka Novel Products (ONPG) is a company dedicated to research and development of solutions for tuberculosis. |  IMIDomics IMIDomics is a company that develops medicine diagnostics and therapeutics to optimize treatment of IMID (immune-mediated inflammatory diseases) patients. | |
Founding Date | Founding Date 2007 | Founding Date 2004 | Founding Date 2000 | Founding Date N/A | Founding Date 2015 |
Type | Type Public | Type Public | Type Public | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations Billerica, US HQ Baltimore, US Philadelphia, US San Diego, US San Francisco, US Seattle, US | Locations Uppsala, SE HQ Barcelona, ES Uppsala, SE Watertown, US | Locations Boulder, US HQ | Locations München, DE HQ | Locations HQ |
Employees | Employees 24840% increase | Employees 582 | Employees 483 | Employees 323% decrease | Employees 3 |
Valuation ($) | Valuation ($) 506.2 m | Valuation ($) N/A | Valuation ($) 396.2 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $137.4m (FY, 2024) | Revenue (est.) $169.6m (FY, 2023) | Revenue (est.) $97.7m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $54.3m (FY, 2024) | Cost of goods $51.9m (FY, 2023) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $83.1m (FY, 2024) | Gross profit $119.9m (FY, 2023) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income ($38.5m) (FY, 2024) | Net income ($31.6m) (FY, 2023) | Net income ($109.2m) (FY, 2022) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 96.5m | Total funding raised N/A | Total funding raised $ 622.5m | Total funding raised N/A | Total funding raised $ 16.5m |
For sources of this data, please see the company profile
View Company Profiles
Olink
HQ
Uppsala, SE
Employees
582
Olink Proteomics is a company providing products and services for human protein biomarker discovery.
View companySomaLogic
HQ
Boulder, US
Employees
483
SomaLogic's breakthrough SOMAscan(tm) technology unlocks protein biomarkers for life sciences research, drug discovery and development, and new diagnostics.
View companyOtsuka Novel Products
HQ
München, DE
Otsuka Novel Products (ONPG) is a company dedicated to research and development of solutions for tuberculosis.
View companyIMIDomics
HQ
Employees
3
IMIDomics is a company that develops medicine diagnostics and therapeutics to optimize treatment of IMID (immune-mediated inflammatory diseases) patients.
View company